Dr. Herman F. Staats' lab at Duke University focuses on creating a safe and effective environment for research on infectious diseases. The lab is part of a specialized center that helps scientists study pathogens and develop strategies for pandemic preparedness. This includes maintaining advanced biocontainment facilities and providing essential training for researchers working with dangerous microbes.

Dr. Richard F Keep's lab focuses on understanding how inflammation in the brain contributes to Alzheimer's disease. They are investigating the role of a specific protein, junctional adhesion molecule-A (JAM-A), in attracting immune cells called neutrophils to the brain, which may harm brain function. By studying these processes, the lab aims to uncover new therapeutic approaches to slow down cognitive decline in Alzheimer's patients.

Dr. Jiann-Jyh Lai's lab at the University of Massachusetts Medical School focuses on understanding how the immune system detects cell injury and initiates inflammatory responses. Their research specifically investigates novel receptors and ligands that are involved in this process, which can impact various diseases. By using both human and mouse models, the lab aims to uncover new mechanisms that could lead to innovative treatments for conditions like stroke, heart attacks, and cancer.

Dr. Lily Q Dong's lab focuses on understanding how specific proteins in the body can help to control inflammation and metabolic health, particularly in the context of obesity. The research highlights a protein called ABHD17B that may be key in helping macrophages function properly to reduce inflammation associated with excess body fat. By studying these mechanisms, the lab aims to uncover potential new treatments for metabolic diseases like type 2 diabetes that arise from obesity.

Dr. Judy H. Cho's lab at the Icahn School of Medicine focuses on understanding the genetic and molecular mechanisms behind inflammatory bowel disease (IBD), particularly Crohn's disease. The research explores how specific genetic mutations affect blood cells and tissue response, especially in challenging cases like perianal fistulae. Through advanced techniques like single-cell transcriptomics and multi-omic analysis, the lab aims to identify new therapeutic targets and improve patient outcomes in IBD.

Dr. Sarah Cobey's lab at the University of Chicago focuses on understanding immune responses to influenza vaccination. They use computational models to explore how individual differences affect vaccine effectiveness, and the lab aims to improve vaccine design based on these insights. By analyzing immune responses over time, they seek to identify factors that contribute to better protection against influenza infection.

Dr. Beatriz Ma Fontoura's lab focuses on understanding the nuclear export of influenza virus mRNA and how various proteins facilitate this process. By investigating specific RNA-binding proteins and their roles in the export pathways, the lab aims to uncover fundamental mechanisms of viral replication. This knowledge could lead to new antiviral strategies against influenza virus infections.

Dr. Weizhou Zhang's lab at the University of Florida researches innovative cancer therapies that focus on developing new drugs that can dismantle cancer cells while also harnessing the body's immune system. They specifically use a technology called Proteolysis-targeting chimera (PROTAC) to target and degrade specific proteins involved in cancer, particularly in melanoma, renal cell carcinoma, and breast cancer metastasis. The lab's work aims to improve cancer treatment outcomes by addressing both tumor cells and the immune environment.

Dr. Charles A Parkos at the University of Michigan focuses on understanding how HIV infection disrupts the intestinal barrier, leading to inflammation and various health complications in people living with HIV. His lab investigates the interaction between HIV-infected cells and intestinal epithelial cells, aiming to uncover the molecular pathways that contribute to these diseases. By tackling these issues, the lab hopes to develop targeted therapies that can improve overall health for individuals affected by HIV.

Dr. Casey T. Weaver's lab at the University of Alabama at Birmingham focuses on understanding how the immune system protects the intestines, particularly in the context of inflammatory bowel disease and neonatal health. The lab investigates the roles of specialized immune cells and cytokines in defending against harmful bacteria, maintaining intestinal health, and preventing infections in early life. Their research aims to uncover new treatment strategies for conditions like inflammatory bowel disease and late-onset sepsis in neonates.

Dr. Ke Jian Liu's lab at Stony Brook University focuses on understanding how intracerebral hemorrhage (ICH) causes brain damage, specifically through a compound called zinc protoporphyrin (ZnPP). Their research investigates the relationship between tissue hypoxia, oxidative stress, and ZnPP formation in the brain after hemorrhage. The lab aims to explore whether repurposing certain FDA-approved drugs can provide new therapeutic options to reduce brain injury caused by ICH.

Dr. Bruce P. Bean's lab focuses on understanding how different types of ion channels in neurons work together to control how neurons fire. By studying the interactions between various channels, such as sodium, calcium, and potassium, the lab aims to design new drugs that can precisely target specific types of neurons involved in pain and epilepsy. This pioneering research could lead to more effective treatments for these conditions.

Dr. Thomas Benedict Bartnikas's lab at Brown University focuses on understanding how the body balances iron and manganese levels, which are necessary for health but can be toxic in excess. The lab investigates how inherited conditions, such as hereditary hemochromatosis, affect the regulation and absorption of these metals. Their research helps to uncover the fundamental processes that maintain the balance of important nutrients while preventing toxicity.

Dr. Nobuyuki Ishibashi's lab at Boston University Medical Campus focuses on improving neurological outcomes for children with congenital heart disease (CHD) using innovative cell therapy approaches. The lab is investigating how bone marrow-derived mesenchymal stromal cells (BM-MSCs) can be delivered via cardiopulmonary bypass during cardiac surgeries to repair brain tissue and enhance recovery. Their research includes understanding the molecular mechanisms of these therapies and identifying bioactive molecules that could lead to new treatments.

Barak Blum's research lab at the University of Wisconsin-Madison focuses on understanding the islets of Langerhans, which play a critical role in insulin regulation and diabetes. The lab explores how changes in cell communication and tissue architecture during islet expansion impact their ability to function properly, especially in the context of type 2 and gestational diabetes. By investigating the Slit-Robo signaling pathway, the lab aims to uncover new ways to promote healthy islet function and improve glucose regulation in people at risk of diabetes.

Dr. X. Long Zheng's lab at the University of Kansas Medical Center studies a rare blood disorder called immune thrombotic thrombocytopenic purpura (iTTP). They focus on understanding how certain autoantibodies disrupt normal blood function and how genetic factors might contribute to this disease. By using models and advanced techniques, the lab aims to uncover new insights that could lead to better treatments for patients suffering from iTTP and similar conditions.

Dr. Stephen C. Jameson's lab at the University of Minnesota focuses on understanding how aging affects the immune system, particularly the role of senescent cells in reducing the body's ability to respond to infections like COVID-19. The lab explores how these senescent cells can create a hostile environment for immune responses and investigates potential therapies to eliminate them. Additionally, the lab studies how certain CD8+ T cells can lose function without being deleted, which is crucial for preventing autoimmune diseases.

Dr. Yvonne M. W. Janssen-Heininger's lab at the University of Vermont studies lung cancer, focusing on how a molecular process involving a protein called glutaredoxin affects cancer cell survival and resistance to treatment. The lab is investigating how changes in glutathione metabolism can influence lung tumor growth and how these insights can lead to potential new therapies for lung cancer patients. By understanding the cancer's metabolic adaptations, the lab aims to develop strategies to enhance the effectiveness of existing treatments like cisplatin.

Dr. Chunyuan Jin's lab focuses on understanding how formaldehyde, a chemical found in many environments, affects our DNA and contributes to cancer. The research aims to uncover how formaldehyde interacts with proteins that help package our DNA, leading to potential changes in gene expression and chromosomal stability, which might be linked to cancer development. This work could reveal new insights into how environmental toxins impact our health.

Dr. Yishi Jin's research lab focuses on understanding how synapses and axons develop and maintain their functions throughout the life of an organism. Using the tiny worm C. elegans, the lab investigates the complexities of nerve connections to gain insights into the molecular mechanisms that govern nerve function and repair. This research is crucial for identifying how disruptions can lead to neurological disorders, offering hope for better treatments and understanding of such conditions.